NCT00654537View on ClinicalTrials.gov

STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

PHASE3CompletedINTERVENTIONAL
Enrollment

5,625

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

October 31, 2004

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin

DRUG

Atorvastatin

DRUG

Pravastatin

DRUG

Simvastatin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY